Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

USA - NYSE:HUN - US4470111075 - Common Stock

10.55 USD
-0.1 (-0.94%)
Last: 9/15/2025, 11:57:00 AM
Fundamental Rating

3

Taking everything into account, HUN scores 3 out of 10 in our fundamental rating. HUN was compared to 83 industry peers in the Chemicals industry. HUN has a bad profitability rating. Also its financial health evaluation is rather negative. HUN does not seem to be growing, but still is valued expensively. HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

HUN had negative earnings in the past year.
In the past year HUN had a positive cash flow from operations.
Of the past 5 years HUN 4 years were profitable.
Each year in the past 5 years HUN had a positive operating cash flow.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -4.72%, HUN is doing worse than 69.88% of the companies in the same industry.
Looking at the Return On Equity, with a value of -12.03%, HUN is doing worse than 68.67% of the companies in the same industry.
HUN's Return On Invested Capital of 0.72% is on the low side compared to the rest of the industry. HUN is outperformed by 77.11% of its industry peers.
HUN had an Average Return On Invested Capital over the past 3 years of 3.85%. This is below the industry average of 6.34%.
Industry RankSector Rank
ROA -4.72%
ROE -12.03%
ROIC 0.72%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

HUN has a Operating Margin of 0.87%. This is in the lower half of the industry: HUN underperforms 79.52% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 13.74%, HUN is doing worse than 75.90% of the companies in the same industry.
HUN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.87%
PM (TTM) N/A
GM 13.74%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HUN is destroying value.
HUN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HUN has less shares outstanding
HUN has a worse debt/assets ratio than last year.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

HUN has an Altman-Z score of 1.61. This is a bad value and indicates that HUN is not financially healthy and even has some risk of bankruptcy.
HUN has a worse Altman-Z score (1.61) than 63.86% of its industry peers.
HUN has a debt to FCF ratio of 15.19. This is a negative value and a sign of low solvency as HUN would need 15.19 years to pay back of all of its debts.
HUN has a Debt to FCF ratio (15.19) which is in line with its industry peers.
HUN has a Debt/Equity ratio of 0.59. This is a neutral value indicating HUN is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.59, HUN is in the better half of the industry, outperforming 61.45% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 15.19
Altman-Z 1.61
ROIC/WACC0.09
WACC8.16%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.43 indicates that HUN should not have too much problems paying its short term obligations.
HUN has a worse Current ratio (1.43) than 74.70% of its industry peers.
HUN has a Quick Ratio of 1.43. This is a bad value and indicates that HUN is not financially healthy enough and could expect problems in meeting its short term obligations.
HUN has a Quick ratio of 0.85. This is in the lower half of the industry: HUN underperforms 77.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.85
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

3

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2400.00%.
Looking at the last year, HUN shows a decrease in Revenue. The Revenue has decreased by -1.56% in the last year.
The Revenue has been decreasing by -2.35% on average over the past years.
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%

3.2 Future

HUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 115.44% yearly.
The Revenue is expected to grow by 1.24% on average over the next years.
EPS Next Y-823.88%
EPS Next 2Y-9.06%
EPS Next 3Y115.44%
EPS Next 5YN/A
Revenue Next Year-4.34%
Revenue Next 2Y-0.04%
Revenue Next 3Y1.24%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

HUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HUN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

HUN's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HUN indicates a rather cheap valuation: HUN is cheaper than 84.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.68
EV/EBITDA 10.47
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HUN's earnings are expected to grow with 115.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-9.06%
EPS Next 3Y115.44%

More info and screens

8

5. Dividend

5.1 Amount

HUN has a Yearly Dividend Yield of 8.97%, which is a nice return.
Compared to an average industry Dividend Yield of 3.43, HUN pays a better dividend. On top of this HUN pays more dividend than 92.77% of the companies listed in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 8.97%

5.2 History

On average, the dividend of HUN grows each year by 9.05%, which is quite nice.
HUN has paid a dividend for at least 10 years, which is a reliable track record.
HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of HUN are negative and hence is the payout ratio. HUN will probably not be able to sustain this dividend level.
The dividend of HUN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-51.63%
EPS Next 2Y-9.06%
EPS Next 3Y115.44%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

More info and screens

HUNTSMAN CORP

NYSE:HUN (9/15/2025, 11:57:00 AM)

10.55

-0.1 (-0.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners88.68%
Inst Owner Change4.9%
Ins Owners5.31%
Ins Owner Change0.85%
Market Cap1.83B
Analysts64.76
Price Target10.75 (1.9%)
Short Float %11.43%
Short Ratio3.97
Dividend
Industry RankSector Rank
Dividend Yield 8.97%
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-51.63%
Div Incr Years4
Div Non Decr Years17
Ex-Date09-15 2025-09-15 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-32.68%
Min EPS beat(2)-64.52%
Max EPS beat(2)-0.84%
EPS beat(4)1
Avg EPS beat(4)-53.28%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)1
Avg EPS beat(8)-32.62%
EPS beat(12)2
Avg EPS beat(12)-27.18%
EPS beat(16)6
Avg EPS beat(16)-17.7%
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)-3.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.94%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-1.96%
Revenue beat(12)2
Avg Revenue beat(12)-2.01%
Revenue beat(16)3
Avg Revenue beat(16)-2.37%
PT rev (1m)-6.16%
PT rev (3m)-27.13%
EPS NQ rev (1m)-15.88%
EPS NQ rev (3m)-635.51%
EPS NY rev (1m)-64.45%
EPS NY rev (3m)-171.94%
Revenue NQ rev (1m)-0.54%
Revenue NQ rev (3m)-5.45%
Revenue NY rev (1m)-2.27%
Revenue NY rev (3m)-3.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF 13.68
P/OCF 6.13
P/B 0.65
P/tB 1
EV/EBITDA 10.47
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)0.77
FCFY7.31%
OCF(TTM)1.72
OCFY16.31%
SpS33.73
BVpS16.12
TBVpS10.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.72%
ROE -12.03%
ROCE 0.91%
ROIC 0.72%
ROICexc 0.77%
ROICexgc 0.95%
OM 0.87%
PM (TTM) N/A
GM 13.74%
FCFM 2.29%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexcg growth 3Y-54.19%
ROICexcg growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 15.19
Debt/EBITDA 4.93
Cap/Depr 57.69%
Cap/Sales 2.82%
Interest Coverage 0.64
Cash Conversion 88.72%
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.85
Altman-Z 1.61
F-Score5
WACC8.16%
ROIC/WACC0.09
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-242.86%
EPS Next Y-823.88%
EPS Next 2Y-9.06%
EPS Next 3Y115.44%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.56%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-7.37%
Revenue Next Year-4.34%
Revenue Next 2Y-0.04%
Revenue Next 3Y1.24%
Revenue Next 5YN/A
EBIT growth 1Y142.86%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year121.13%
EBIT Next 3Y62.78%
EBIT Next 5YN/A
FCF growth 1Y-46.18%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y-37.71%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%